CA2276542C - Nouveau peptide, une methode pour sa preparation et une composition pharmaceutique renfermant ce peptide - Google Patents

Nouveau peptide, une methode pour sa preparation et une composition pharmaceutique renfermant ce peptide Download PDF

Info

Publication number
CA2276542C
CA2276542C CA 2276542 CA2276542A CA2276542C CA 2276542 C CA2276542 C CA 2276542C CA 2276542 CA2276542 CA 2276542 CA 2276542 A CA2276542 A CA 2276542A CA 2276542 C CA2276542 C CA 2276542C
Authority
CA
Canada
Prior art keywords
trp
ile
peptide
glu
tyr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2276542
Other languages
English (en)
Other versions
CA2276542A1 (fr
Inventor
Vladislav I. Deigin
Andrei Korotkov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunotech Developments Inc
Original Assignee
Immunotech Developments Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotech Developments Inc filed Critical Immunotech Developments Inc
Priority to CA 2276542 priority Critical patent/CA2276542C/fr
Publication of CA2276542A1 publication Critical patent/CA2276542A1/fr
Application granted granted Critical
Publication of CA2276542C publication Critical patent/CA2276542C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2276542 1999-06-28 1999-06-28 Nouveau peptide, une methode pour sa preparation et une composition pharmaceutique renfermant ce peptide Expired - Fee Related CA2276542C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2276542 CA2276542C (fr) 1999-06-28 1999-06-28 Nouveau peptide, une methode pour sa preparation et une composition pharmaceutique renfermant ce peptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2276542 CA2276542C (fr) 1999-06-28 1999-06-28 Nouveau peptide, une methode pour sa preparation et une composition pharmaceutique renfermant ce peptide

Publications (2)

Publication Number Publication Date
CA2276542A1 CA2276542A1 (fr) 2000-12-28
CA2276542C true CA2276542C (fr) 2013-07-30

Family

ID=30774430

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2276542 Expired - Fee Related CA2276542C (fr) 1999-06-28 1999-06-28 Nouveau peptide, une methode pour sa preparation et une composition pharmaceutique renfermant ce peptide

Country Status (1)

Country Link
CA (1) CA2276542C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10376557B2 (en) 2006-06-13 2019-08-13 Helix Biomedix Inc. Peptide fragments for inducing synthesis of extracellular matrix proteins

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007342353B2 (en) 2007-01-05 2012-06-28 Helix Biomedix Inc. Short bio-active peptides for cellular and immunological modulation
CN101855235B (zh) 2007-10-29 2013-04-24 赫里克斯生物医疗公司 保护性皮肤护理四肽
CA2770790A1 (fr) * 2009-08-10 2011-02-17 Immunotech Developments Inc. Vaccin ayant un adjuvant peptidique pour induire une reponse immunitaire specifique afin de traiter une infection virale et d'autres maladies
RU2458935C1 (ru) * 2011-02-18 2012-08-20 Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") Средство для коррекции метаболического синдрома
WO2013172728A1 (fr) * 2012-05-18 2013-11-21 Общество С Ограниченной Ответственностью "Цитонир" Produit de correction du syndrome métabolique

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10376557B2 (en) 2006-06-13 2019-08-13 Helix Biomedix Inc. Peptide fragments for inducing synthesis of extracellular matrix proteins

Also Published As

Publication number Publication date
CA2276542A1 (fr) 2000-12-28

Similar Documents

Publication Publication Date Title
US4024248A (en) Peptides having LH-RH/FSH-RH activity
CA1311583C (fr) Derives peptides et leur application, surtout en therapie
US4612365A (en) Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
EP0559756B1 (fr) Agents nonapeptidiques antagonistes de la bombesine
US4470926A (en) Medicaments containing thymosin alpha 1 fragments and having an immunostimulant action, and fragments of thymosin alpha 1
US5416073A (en) Growth hormone-releasing peptides and method of treating animals, therewith
AU602483B2 (en) Immunoregulatory peptides
SK282267B6 (sk) Bombezínu antagonistický peptid, farmaceutický prostriedok s jeho obsahom a jeho použitie
CA2276542C (fr) Nouveau peptide, une methode pour sa preparation et une composition pharmaceutique renfermant ce peptide
AU705418B2 (en) Peptides having immunomodulatory activity
FI67691C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara peptider
US6159940A (en) Method for modulating hemopoiesis
US6184208B1 (en) Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
FI111462B (fi) Menetelmä motiliinityyppisten polypeptidien valmistamiseksi, joilla on ruoansulatuskanavan motiliteettia stimuloivaa aktiivisuutta
HU189550B (en) Process for producing deca-, undeca-, dodeca- and trideca-peptides for enhancing immunological resistance the structure of which is analogue with the n-terminal part of human serum-prealbumin
EP0297456A2 (fr) Peptides immunosuppressifs
CA1157466A (fr) Peptides ayant des proprietes ressemblant a celles de la thymopoietine
US4487764A (en) New peptides and a process for their preparation
US6410515B1 (en) Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
CA2185212A1 (fr) Derives de peptides
NZ226178A (en) Linear and cyclic analogues of growth hormone releasing factor and pharmaceutical compositions
CA2011874C (fr) Peptides sdk, procede de preparation et composes therapeutiques les contenants
EP0517464A1 (fr) Peptides de régulation du système immunitaire et du système nerveux
US6248716B1 (en) Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
JPS62501502A (ja) 免疫調節性ペプチド

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160628